Insider Transactions in Q1 2021 at Rvl Pharmaceuticals PLC (RVLP)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 24
2021
|
Gregory L Cowan Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,505
-6.91%
|
$22,020
$4.46 P/Share
|
|
Jan 24
2021
|
Fred G Weiss Director |
SELL
Payment of exercise price or tax liability
|
Direct |
5,505
-6.34%
|
$22,020
$4.46 P/Share
|
|
Jan 24
2021
|
Tina Marie De Vries EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
9,597
-5.74%
|
$38,388
$4.46 P/Share
|
|
Jan 24
2021
|
Andrew J. Einhorn Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,668
-5.78%
|
$38,672
$4.46 P/Share
|
|
Jan 24
2021
|
Christopher Klein General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
9,605
-4.22%
|
$38,420
$4.46 P/Share
|
|
Jan 24
2021
|
James Schaub EVP and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,687
-2.95%
|
$38,748
$4.46 P/Share
|